Moderna advances two vax candidates against Omicron variants
The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5.
Tag: Pharma interest
Fools rush in where angels fear to tread – how the pharmacy guild failed on chronic pain
Turns out chronic pain MedsCheck is an intervention few pharmacists want to deliver, and few patients want to be involved with. Another multi-million dollar pharmacy…
Trials to begin on new Australian COVID-19 vaccine
SA researchers are behind the new DNA vaccine that targets the Omicron variant.
Moderna says its new booster is better than original against Omicron
he updated vaccine formulation raises antibodies eightfold against the COVID-19 variant, according to preliminary data released by the company.
…
Warning over adverse PPI effect that can lead to seizure: case
A Canadian doctor has shared the case of a patient who developed severe electrolyte imbalance after being continuously prescribed the drugs.
How a potential new cancer treatment sneaks up on tumours
Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumour cells, causing a plethora of side effects. Immunotherapies that…
‘Why I had to quit Northern Queensland PHN’: Dr Nicole Higgins
Dr Nicole Higgins, a former board director on the network, says it has become entangled in a web of 'influential organisations, institutions and re…
Second oral antiviral for COVID-19 on PBS broadens options for GPs
This comes as experts rule out routine use of sotrovimab against circulating subvariants and a new hybrid variant, Deltacron, emerges in Australia.…
Exclusive: Govt axes millions in funding for NPS MedicineWise
Medicines expert Dr Geraldine Moses (PhD) labelled the decision 'ridiculous'.
Ivermectin ‘makes no clinical difference’ in COVID-19: major trial
Early intervention with the much-touted drug fails to keep high-risk patients out of hospital or shorten recovery times,…
